Lone Risperdal Defense Verdict for J&J Overturned
Shellers honored as National Liberty Museum’s “2017 Heroes of Liberty”
The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October 7, 2017 at the Sheraton Philadelphia Downtown Hotel. The Shellers were recognized for their support of the Museum and the community through their nonprofit organizations The Sheller Family Foundation and […]
SCOTUS Ruling Increases Risperdal Suits in PA
Risperdal litigation in Philadelphia courts have increased significantly this year and the trend is likely to continue. Mass torts against Janssen, a Johnson & Johnson subsidiary, over it’s antipsychotic drug Risperdal has nearly tripled in Pennsylvania. Plaintiff attorneys say the biggest cause for the recent influx is the expiration of a tolling agreement between Janssen […]
The Chamber: ‘One More Bullet in J&J’s Gun’
In ‘For Plaintiffs Bar, Taking on J&J Means Battling a Shadow Foe,’ Law.com’s Amanda Bronstad reports on the “intimate relationship” between Johnson & Johnson (J&J) and the U.S. Chamber of Commerce (the Chamber). The U.S. Chamber of Commerce is not a government entity, but a powerful group of lobbyists, the largest in the nation. Plaintiff’s lawyers point out […]
Sheller hits #1 Top 50 Verdicts in Pennsylvania for 2016
Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy who grew female-like breasts after taking the antipsychotic drug Rispderal. The unprecedented $70 Million verdict in damages for physical disfigurement and emotional […]
Researchers Concerned About Over-Prescription of Risperdal
The most recent study published on the use of antipsychotics, such as Risperdal, Zyprexa and Seroquel, in children with ADHD has researchers concerned that there may be an over-prescription problem. The study published January 19, 2017 in The Canadian Journal of Psychiatry shows the same dramatic increase in use of antipsychotics prescribed off-label in children with ADHD, ages 1 […]
Sheller on “Full Measure” TV: Update
The television program “Full Measure with Sharyl Attkisson” updated their segment “Bitter Pill” that featured the story of the Sheller firm’s Risperdal litigation. The updated report included the recent $70 million verdict. See the updated broadcast of “Bitter Pill” with the interview of Stephen Sheller here: http://fullmeasure.news/news/politics/bitter-pills-08-02-2016 See the Sheller.com previous post on the segment […]
$70M Risperdal Verdict
In the Philly Inquirer July 2, 2016: Philadelphia jury pins $70m verdict on Janssen for its Risperdal drug A Philadelphia jury found Friday that the antipsychotic drug Risperdal caused a Tennessee boy to grow breasts and imposed a $70 million verdict on its manufacturer, Janssen Pharmaceuticals. Lawyers for the boy argued that scientists for the […]
Sheller’s Book on Amazon
Now Available on Amazon: Lawyering in Times of Saints and Evil Doers: Lives Touched and Lessons Learned From My Five Decades Fighting For Justice In Lawyering in Times of Saints and Evildoers Stephen A. Sheller, Esq. shares his career experiences that spans over 50 years showing how he became a highly recognized advocate of everyday people, passionately […]
Plaintiffs 3-for-4 in Philadelphia Risperdal trials
Plaintiffs 3-for-4 in Philadelphia Risperdal trials, confident punitive damages will be reintroduced If the results of the first trials are any indication, Janssen Pharmaceuticals might find itself with a hefty price tag connected to more than 1,600 Risperdal cases currently pending in Philadelphia, even without the prospect of paying punitive damages – though an appeal […]
